WallStreetZenWallStreetZen

NASDAQ: PVLA
Palvella Therapeutics Inc Stock Ownership - Who owns Palvella Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Palvella Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kathleen GoinChief Operating Officer2026-05-202,148$9.08
$19.50kBuy
Kathleen GoinChief Operating Officer2026-05-202,154$7.14
$15.38kBuy
Kathleen GoinChief Operating Officer2026-05-2048$111.90
$5.37kSell
Kathleen GoinChief Operating Officer2026-05-20891$111.30
$99.16kSell
Kathleen GoinChief Operating Officer2026-05-203,363$110.35
$371.09kSell
Kathleen GoinChief Operating Officer2026-04-152,148$9.08
$19.50kBuy
Kathleen GoinChief Operating Officer2026-04-152,154$7.14
$15.38kBuy
Kathleen GoinChief Operating Officer2026-04-15100$130.33
$13.03kSell
Kathleen GoinChief Operating Officer2026-04-15639$129.17
$82.54kSell
Kathleen GoinChief Operating Officer2026-04-15561$128.24
$71.94kSell

1 of 4

PVLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PVLA insiders and whales buy or sell their stock.

PVLA Shareholders

What type of owners hold Palvella Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC25.63%3,675,530$435.40MInsider
Wes Kaupinen11.21%1,607,228$190.39MInsider
Suvretta Capital Management LLC8.04%1,153,496$136.64MInstitution
First Light Asset Management LLC6.84%980,758$116.18MInstitution
Bvf Inc6.70%960,989$113.84MInstitution
Frazier Life Sciences Management LP6.15%882,400$104.53MInstitution
Blackrock Inc4.79%686,853$81.36MInstitution
Jennison Associates LLC4.47%640,611$75.89MInstitution
Vanguard Capital Management LLC3.33%477,294$56.54MInstitution
State Street Corp3.20%458,999$54.37MInstitution

1 of 3

PVLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PVLA68.10%31.90%Net BuyingNet Buying
VCEL91.39%8.61%Net SellingNet Selling
TSHA89.36%10.64%Net SellingNet Selling
GENB57.21%42.79%Net BuyingNet Buying
NUVB58.02%41.98%Net BuyingNet Buying
View Top Biotech Stocks

Palvella Therapeutics Stock Ownership FAQ

Who owns Palvella Therapeutics?

Palvella Therapeutics (NASDAQ: PVLA) is owned by 92.45% institutional shareholders, 43.31% Palvella Therapeutics insiders, and 0.00% retail investors. Aquilo Capital Management LLC is the largest individual Palvella Therapeutics shareholder, owning 3.68M shares representing 25.63% of the company. Aquilo Capital Management LLC's Palvella Therapeutics shares are currently valued at $435.40M.

If you're new to stock investing, here's how to buy Palvella Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.